Many Patients with “Chemo Brain” Recover within Five Years

A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially […]

Survivors of Some Childhood Cancers May Face Cognitive Impairment

Survivors of non-central nervous system (CNS) childhood cancers reported a statistically and clinically significantly higher rate of neurocognitive impairment than […]

September Is National Leukemia and Lymphoma Awareness Month

As the month of September brings leukemia and lymphoma into focus, it’s time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention, treatment options, and resources that offer updated leukemia and lymphoma information throughout the year.

Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers

Industrial workers who are exposed to formaldehyde may be at an increased risk of dying from blood and lymphatic cancers, particularly myeloid leukemia but also Hodgkin’s lymphoma and multiple myeloma, according to the results of a study published in the Journal of the National Cancer Institute.

LYN Kinase Affects Sensitivity to Gleevec® in Chronic Myeloid Leukemia

LYN Kinase Affects Sensitivity to Gleevec® in Chronic Myeloid Leukemia A protein structure known as the LYN kinase appears to play an important role in the effectiveness of Gleevec® (imatinib mesylate) in chronic myeloid leukemia (CML) cancer cells. These results were recently published in the Journal of the National Cancer Institute . Chronic myeloid leukemia is a cancer that originates in the immune cells.